刘文超,张晓楠,许龙,张新,秦华,朱长进,马兵
LIU Wenchao,ZHANG Xiaonan,XU Long,ZHANG Xin,QIN Hua,ZHU Changjin,MA Bing

• 1:北京理工大学化学与化工学院
• 2:北京天衡军威医药技术开发有限公司

摘要(Abstract)：

目的 设计合成一系列靛红衍生物，研究其对醛糖还原酶的抑制活性和选择性。方法 以5-溴靛红为起始原料合成5′-溴螺[[1,3]二氧戊环-2,3′-吲哚啉]-2′-酮的三环骨架，然后经N烷基化反应、Suzuki或Heck偶联、水解合成了目标化合物。测定目标化合物对醛糖还原酶的抑制活性和选择性，通过计算机辅助药物设计软件在分子水平上研究化合物与醛糖还原酶活性位点的相互作用模式。结果 设计合成了14个目标化合物，其结构经~1H-NMR、~(13)C-NMR与MS谱确证。化合物6a～6g,8a～8f对醛糖还原酶具有良好的抑制活性和选择性。其中，化合物8d的活性最强，IC_(50)为0.090μmol·L~(-1),与阳性对照药依帕司他相当。分子对接结果显示，化合物7、6b、8a和8d能与醛糖还原酶的活性位点较好结合。结论 构效关系和分子对接研究表明三环结构上N-1位的羧酸基团与C-5侧链上的苯乙烯结构是提高醛糖还原酶抑制活性的关键。甲氧基或者酚羟基的引入可显著改善化合物对醛糖还原酶的抑制活性和选择性。
Objective To design and synthesize a series of isatin derivatives, and to further study their inhibitory activity and selectivity towards aldose reductase(ALR2).Methods The tricyclic skeleton of 5′-bromospiro[[1,3]dioxolane-2,3′-indoline]-2′-one was synthesized with 5-bromoisatin as the starting material.Then the target compounds were synthesized through the procedure of N-alkylation, Suzuki or Heck coupling and hydrolysis.The target compounds were tested for the inhibitory activity and selectivity towards ALR2,and computer-aided drug design software was used to study the interaction mode of compounds with the active site of ALR2 at the molecular level.Results Fourteen target compounds were designed and synthesized, and their structures were confirmed by ~1H-NMR,~(13)C-NMR and MS.Compounds 6a-6g,8a-8f demonstrated well inhibitory activity and selectivity towards ALR2.Among them, compound 8d displayed the highest ALR2 inhibitory activity with an IC_(50) value of 0.090 μmol·L,which was equivalent to the positive control drug epalrestat.The results of molecular docking showed that compounds 7,6b,8a and 8d could bind to the active site of ALR2 in a good way.Conclusion Structure-activity relationship and molecular docking studies show that the acetic acid group at N-1 and styryl side chain at C-5 of the tricyclic skeleton are the key structures to increase the ALR2 inhibitory activity.The introduction of methoxy group or phenolic hydroxyl group significantly improves the inhibitory activity and selectivity of compounds toward ALR2.

关键词(KeyWords)： 醛糖还原酶抑制剂;糖尿病并发症;分子对接
aldose reductase inhibitor;diabetic complication;molecular docking

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金资助项目(21572021)

作者(Author): 刘文超,张晓楠,许龙,张新,秦华,朱长进,马兵
LIU Wenchao,ZHANG Xiaonan,XU Long,ZHANG Xin,QIN Hua,ZHU Changjin,MA Bing

DOI: 10.14066/j.cnki.cn21-1349/r.2021.0398

参考文献(References)：

• [1] MACCARI R,OTTANA R.Targeting aldose reductase for the treatment of diabetes complications and inflam-matory diseases:new insights and future directions[J].J Med Chem,2015,58(5):2047-2067.
• [2] MOU Y Y,YE Z H,LIN H Z,et al.Advances in epidemiological studies of diabetes[J].Diabetes New World (糖尿病新世界),2019,22(4):196-198.
• [3] BROWNLEE M.Biochemistry and molecular cell biology of diabetic complications[J].Nature,2001,414(6865):813-820.
• [4] CHEN H,ZHANG X,ZHANG X,et al.Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity [J].Bioorg Med Chem,2020,28(20):115699-115708.
• [5] LUCA Q,CONCETTINA L M.Aldose reductase inhibitors:2013-present [J].Am J Med,2019,29:199-213.
• [6] LI Q,WANG Z,ZHOU N,et al.Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway [J].Neural Regen Res,2016,11(2):345-351.
• [7] STEFEK M,SOLTESOVA PRNOVA M,MAJEOVA M,et al.Identification of novel aldose reductase inhibitors based on carboxymethylated mercaptotriazinoindole scaffold[J].J Med Chem,2015,58(6):2649-2657.
• [8] DA SETTIMO F,PRIMOFIORE G,DA SETTIMO A,et al.[1,2,4]Triazino[4,3-a]benzimidazole acetic acid derivatives:a new class of selective aldose reductase inhibitors[J].J Med Chem,2001,44(25):4359-4369.
• [9] GERONIKAKI A,BABAEV E,DEARDEN J,et al.Design,synthesis,computational and biological evaluation of new anxiolytics[J].Bioorgan Med Chem,2004,12(24):6559-6568.
• [10] ABDEL-RAHMAN A,KESHK E,HANNA M,et al.Synthesis and evaluation of some new spiro indoline based heterocycles as potentially active antimicrobial agents[J].Bioorgan Med Chem,2004,12(9):2483-2488.
• [11] IBRAR A,TEHSEEN Y,KHAN I,et al.Coumarin-thiazole and oxadiazole derivatives:Synthesis,bioactivity and docking studies for aldose/aldehyde reductase inhibitors [J].Bioorg Chem,2016,68(35):177-186.
• [12] QIN X Y,HAO X,HAN H,et al.Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones [J].J Med Chem,2015,58(3):1254-1267.
• [13] HAYMAN S,KINOSHITA J H.Isolation and properties of lens aldose reductase[J].J Biol Chem,1965,240(2):877-882.
• [14] MOTTA C L,STEFANIA S,LAURA M,et al.Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity[J].J Med Chem,2007,50(20):4917-4927.
• [15] El-KABBANI O,RAMSLAND P,DARMANIN C,et al.Structure of human aldose reductase holoenzyme in complex with statil:An approach to structure-based inhibitor design of the enzyme[J].Proteins,2003,50(2):230-238.